Northland raised the firm’s price target on BioLife Solutions (BLFS) to $34 from $31 and keeps an Outperform rating on the shares, which were also ...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will ...

BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to loss of $0.70 per share a year ...

BOTHELL, Wash., Dec. 16, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell and ...

BOTHELL, Wash., March 2, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies, today announced ...

BOTHELL, Wash., March 22, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction ...

) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified BioLife Solutions as such a stock due to the following factors: BLFS has an average ...

The latest price target for BioLife Solutions (NASDAQ:BLFS) was reported by HC Wainwright & Co. on August 8, 2025. The analyst firm set a price target for $32.00 expecting BLFS to rise to within 12 ...

BioLife Solutions, a leading provider of bioproduction tools and services, is poised for growth as the demand for biologics and regenerative medicine increases. CryoStor and HypoThermosol have shown ...

BioLife Solutions (BLFS-2.70%) is starting the week with a bang. On Monday morning, the company announced it has signed a definitive agreement to purchase privately held SciSafe. The price is $30 ...